These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 2941574)

  • 21. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
    Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
    Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistological analysis of skin reaction to My1 derived from Mycobacterium leprae.
    Narayanan RB; Ramu G; Malaviya GN; Sinha S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):46-51. PubMed ID: 3519804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
    Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
    Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pityriasis rosea (Gibert): abnormal distribution pattern of antigen presenting cells in situ.
    Bos JD; Huisman PM; Krieg SR; Faber WR
    Acta Derm Venereol; 1985; 65(2):132-7. PubMed ID: 2408415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological markers of Langerhans' cells in mycosis fungoides skin lesions.
    Tjernlund U
    Acta Derm Venereol; 1982; 62(3):241-3. PubMed ID: 6179366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in the number and morphology of Langerhans' cells in the epidermal component of squamous cell carcinomas.
    Alcalay J; Goldberg LH; Wolf JE; Kripke ML
    Arch Dermatol; 1989 Jul; 125(7):917-20. PubMed ID: 2742388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parasitism of antigen presenting cells in hyperbacillary leprosy.
    Poulter LW; Collings LA; Tung KS; Waters MF
    Clin Exp Immunol; 1984 Mar; 55(3):611-7. PubMed ID: 6368061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
    Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
    Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.
    Girolomoni G; Valle MT; Zacchi V; Costa MG; Giannetti A; Manca F
    Immunology; 1996 Feb; 87(2):310-6. PubMed ID: 8698396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus.
    Caligaris-Cappio F; Bergui L; Tesio L; Ziano R; Camussi G
    Clin Exp Immunol; 1985 Jan; 59(1):185-9. PubMed ID: 3156013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocompetent cells of fixed drug eruption.
    Visa K; Käyhkö K; Stubb S; Reitamo S
    Acta Derm Venereol; 1987; 67(1):30-5. PubMed ID: 2436411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
    Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
    Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients.
    Sloane JP; Thomas JA; Imrie SF; Easton DF; Powles RL
    J Clin Pathol; 1984 Aug; 37(8):919-30. PubMed ID: 6381547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
    Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
    Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DR-antigen bearing keratinocytes in various dermatologic disorders.
    Smolle J
    Acta Derm Venereol; 1985; 65(1):9-13. PubMed ID: 2578718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).
    Barnett AJ; Tait BD; Barnett MA; Toh BH
    Clin Exp Immunol; 1989 Apr; 76(1):24-9. PubMed ID: 2525437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative and morphologic changes of Langerhans' cells after ultraviolet A irradiation of human epidermis.
    Liu HN; Muller SA; Schroeter AL
    Acta Derm Venereol; 1987; 67(5):411-6. PubMed ID: 2448992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local involvement of antigen-presenting cells and activated T cells in perilesional and clinically uninvolved skin in pemphigus vulgaris.
    Mashkilleyson N; Konttinen YT; Visa K
    Acta Derm Venereol; 1989; 69(5):424-8. PubMed ID: 2572110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.